Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to assess the safety and immunogenicity of a malaria vaccine in healthy children aged 5-60 months; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Malaria vaccine candidate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: RECRUITING